eMultipleSclerosis Review - CM

About eMultipleSclerosis Review - CM Android App

eMultipleSclerosis Review is a no-cost CME program developed by Johns Hopkins University School of Medicine (JHUSOM) in partnership with DKBmed. Expert insight and analysis providing information directly relevant to multiple sclerosis care, through topic-focused newsletters summarizing the peer-reviewed literature with accompanying podcasts to illustrate how to apply that information in the clinic.

eMultipleSclerosis Review is part of the highly successful eLiterature Review series. Over 50,000 health care providers are subscribed to eLiterature Review in areas such as viral hepatitis, primary care, pulmonology, HIV, cystic fibrosis, and diabetes. Join your colleagues in this highly-rated educational program.

eMultipleSclerosis Review Volume 3 covers key topics such as:
-Evaluating conflicting treatment approaches: early aggressive versus treatment escalation
-Incorporating shared decision-making into your practice
-Assessing new and emerging MS treatments
-Addressing burdensome symptoms of MS
-Minimizing MS relapses in pregnancy and postpartum

It is practically impossible for time-pressed clinicians to stay current with new clinical developments by reading medical literature alone, despite the value of doing so. To address this, the Johns Hopkins University School of Medicine (JHUSOM), in partnership with DKBmed, has enhanced the way clinicians receive this vital information through our highly successful eLiterature Review series, spanning a variety of disease states and covering a wide range of clinical expertise. The nuances of each disease require a tailored approach to facilitate optimal learning techniques and knowledge retention. In previous eLiterature Review, some programs have been specifically directed to the specialist practitioner (eg, eOphthalmology, eNeonatalogy), but the majority have targeted a combination of both specialists and primary care clinicians that treat patients with chronic disease (eg, eDiabetes, eViralHepatitis).